BioSpace News Archive

PROOF-HD is designed to replicate previous findings of pridopidine demonstrating maintenance of functional capacity in early Huntington’s Disease patients

Biopharmaceutical company Alvotech announced that its parent company, Alvotech Holdings SA, has successfully completed a $65 million private placement round.

Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins,today announced that two scientific manuscripts have been published in two leading journals

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that its subsidiary, Talem Therapeutics, entered into a collaboration with Twist Bioscience Corporation (NASDAQ: TWST),

Datavant, the leader in helping healthcare organizations safely connect and exchange their data, and Castor, a leading provider of clinical trial technology, today announced a partnership designed to increase clinical trial efficiency and enable life sciences companies and CROs to more efficiently use real-world data.

The International Myeloma Working Group, a body of the world’s top myeloma experts established and supported by the International Myeloma Foundation, has created a new way to identify which patients with smoldering multiple myeloma are candidates for early treatment and clinical trials

Premium Vision powers the telehealth technology which allows customers to easily renew their contact lens prescription online from the comfort of home

QIC Clinics Collaborate to Share Data and Improve Outcomes for People with Type 1 Diabetes

Crown Bioscience, a JSR Life Sciences company, today announces the opening of a new oncology-focused research facility in Zhongshan, China to satisfy increased customer demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201027005098/en/ CrownBio’s New Zhongshan, China Facility (Photo: Business Wire) In addition to the Company’s four facilitie

Halberd Corporation (OTC PINK: HALB ) has retained the services of a prestigious Pittsburgh, PA law firm, Ference & Associates , to handle its intellectual property matters. The initial application focuses on patenting Halberds base Covid-19 antibody as well as an entire new class of antibody conjugate.